Records containing: Tauopathies
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-06-03Global Study to Investigate Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
-
CLINICAL_TRIALS study record update · 2026-04-24Center Without Walls for Imaging Proteinopathies With PET (CW2IP2): Phase I Pilot Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-M503
-
CLINICAL_TRIALS study record update · 2026-03-27A Randomized, Placebo-Controlled, Double-Blind Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
-
CLINICAL_TRIALS study record update · 2026-03-27Global Study to Investigate Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
-
CLINICAL_TRIALS study record update · 2026-02-27An Open Label Extension of XPro1595 in Patients With Alzheimer's Disease That Have Completed a Phase 1 or Phase 2 Study With XPro1595
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-07Center Without Walls for Imaging Proteinopathies With PET (CW2IP2): Imaging and Diagnostic Assessments
-
CLINICAL_TRIALS study record update · 2025-12-31Clinical Validation of the Use of Blood Biomarkers for the Diagnosis and Monitoring of Alzheimer's Disease
-
CLINICAL_TRIALS study record update · 2025-12-29[18F]NIDF PET Imaging in Tau-related Diseases
-
CLINICAL_TRIALS study record update · 2025-12-23Center Without Walls for Imaging Proteinopathies With PET (CW2IP2): Phase I Pilot Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 18F-JSS20-183A
-
CLINICAL_TRIALS study record update · 2025-11-19Center Without Walls for Imaging Proteinopathies With PET (CW2IP2): Phase I Pilot Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15
-
CLINICAL_TRIALS study record update · 2025-02-14Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems
-
CLINICAL_TRIALS study record update · 2025-02-14A Phase Ib/IIa Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Immunogenicity of Different Doses, Regimens and Combinations of Tau Targeted Vaccines in Subjects With Early Alzheimer's Disease
-
CLINICAL_TRIALS study record update · 2025-02-11Tau PET/CT in Various Tau-Related Disease Patients
-
CLINICAL_TRIALS study record update · 2024-09-19Neurodegenerative Diseases Progression Markers (MARKERS-NDD): a Real-world Data Longitudinal Prospective Study
-
CLINICAL_TRIALS study record update · 2024-02-13CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease
-
CLINICAL_TRIALS study record update · 2023-12-29Creating Harmony at HOME: A Pilot Study of a Telehealth Based Program for Rural Caregivers' Ability to Adapt Home Environments for Adults With ADRD
-
CLINICAL_TRIALS study record update · 2023-09-28A Phase 2, Randomized, Placebo-Controlled, Double-Blind Study of XPro1595 in Patients With Mild Cognitive Impairment (MCI) With Biomarkers of Inflammation
-
CLINICAL_TRIALS study record update · 2023-06-15A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of APNmAb005 in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2022-09-02Single-arm, Single-center, Non-randomized, Open-label Study on the Application of Amyloid Imaging Agent [18F]Florbetaben（18FBB） PET/CT Imaging to Distinguish Non-cognitively Impaired Subjects and Mild to Moderate Alzheimer Disease Subjects in Chinese Population
-
CLINICAL_TRIALS study record update · 2020-06-30A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Efficacy of NA-831 in Alzheimer Patients With Mild Cognitive Impairment
-
CLINICAL_TRIALS study record update · 2019-12-06Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations
-
CLINICAL_TRIALS study record update · 2017-11-06ClinicalTrials.gov study NCT02294851
-
CLINICAL_TRIALS study record update · 2016-12-16Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Clinically Diagnosed Tauopathies in Comparison to Healthy Subjects
-
CLINICAL_TRIALS study record update · 2016-08-09Retrospective Analysis of the Comparative Effectiveness of MCI and Dementia Treatment Protocols in a Community-based Specialty Dementia Practice
-
CLINICAL_TRIALS study record update · 2012-10-01The Long-Term Safety and Efficacy Follow-up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD